225 related articles for article (PubMed ID: 32029730)
1. Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus.
Wang XM; Lu Y; Song YM; Dong J; Li RY; Wang GL; Wang X; Zhang SD; Dong ZH; Lu M; Wang SY; Ge LY; Luo GD; Ma RZ; George Rozen S; Bai F; Wu D; Ma LL
Nat Commun; 2020 Feb; 11(1):739. PubMed ID: 32029730
[TBL] [Abstract][Full Text] [Related]
2. Aristolochic Acid in the Etiology of Renal Cell Carcinoma.
Hoang ML; Chen CH; Chen PC; Roberts NJ; Dickman KG; Yun BH; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1600-1608. PubMed ID: 27555084
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
[TBL] [Abstract][Full Text] [Related]
4. Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus.
Shi X; Pang Q; Nian X; Jiang A; Shi H; Liu W; Gan X; Gao Y; Yang Y; Ji J; Tan X; Xiao C; Zhang W
Sci Rep; 2023 Jun; 13(1):9778. PubMed ID: 37328520
[TBL] [Abstract][Full Text] [Related]
5. Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.
Malouf GG; Zhang J; Yuan Y; Compérat E; Rouprêt M; Cussenot O; Chen Y; Thompson EJ; Tannir NM; Weinstein JN; Valero V; Khayat D; Spano JP; Su X
Mol Oncol; 2015 Jan; 9(1):32-43. PubMed ID: 25126716
[TBL] [Abstract][Full Text] [Related]
6. Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study.
Wang G; Hou J; Ma L; Xie J; Yin J; Xu D; Chang W; Tan X; Su T; Zhang H; Cao G
Cancer Epidemiol; 2012 Apr; 36(2):177-82. PubMed ID: 22000673
[TBL] [Abstract][Full Text] [Related]
7. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.
Hsieh JJ; Chen D; Wang PI; Marker M; Redzematovic A; Chen YB; Selcuklu SD; Weinhold N; Bouvier N; Huberman KH; Bhanot U; Chevinsky MS; Patel P; Pinciroli P; Won HH; You D; Viale A; Lee W; Hakimi AA; Berger MF; Socci ND; Cheng EH; Knox J; Voss MH; Voi M; Motzer RJ
Eur Urol; 2017 Mar; 71(3):405-414. PubMed ID: 27751729
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.
Jelaković B; Castells X; Tomić K; Ardin M; Karanović S; Zavadil J
Int J Cancer; 2015 Jun; 136(12):2967-72. PubMed ID: 25403517
[TBL] [Abstract][Full Text] [Related]
9. Genomic features of renal cell carcinoma with venous tumor thrombus.
Warsow G; Hübschmann D; Kleinheinz K; Nientiedt C; Heller M; Van Coile L; Tolstov Y; Trennheuser L; Wieczorek K; Pecqueux C; Gasch C; Kuru T; Nyarangi-Dix J; Hatiboglu G; Teber D; Perner S; Stenzinger A; Roth W; Hadaschik B; Pahernik S; Jäger D; Grüllich C; Duensing A; Eils R; Schlesner M; Sültmann H; Hohenfellner M; Duensing S
Sci Rep; 2018 May; 8(1):7477. PubMed ID: 29748622
[TBL] [Abstract][Full Text] [Related]
10. Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population.
Zhang S; Wang B; Zhang F; Ye J; Ge L; Ma L
Med Sci Monit; 2019 Apr; 25():2959-2965. PubMed ID: 31007253
[TBL] [Abstract][Full Text] [Related]
11. Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
Tennenbaum DM; Manley BJ; Zabor E; Becerra MF; Carlo MI; Casuscelli J; Redzematovic A; Khan N; Arcila ME; Voss MH; Feldman DR; Motzer RJ; Benfante NE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA
Urol Oncol; 2017 Aug; 35(8):532.e7-532.e13. PubMed ID: 28408295
[TBL] [Abstract][Full Text] [Related]
12. Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
Liu L; Guo R; Zhang X; Liang Y; Kong F; Wang J; Xu Z
Biosci Trends; 2017 May; 11(2):214-220. PubMed ID: 28260718
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.
Hakimi AA; Chen YB; Wren J; Gonen M; Abdel-Wahab O; Heguy A; Liu H; Takeda S; Tickoo SK; Reuter VE; Voss MH; Motzer RJ; Coleman JA; Cheng EH; Russo P; Hsieh JJ
Eur Urol; 2013 May; 63(5):848-54. PubMed ID: 23036577
[TBL] [Abstract][Full Text] [Related]
14. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
Front Oncol; 2021; 11():646338. PubMed ID: 34249685
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
16. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma.
Yu Z; Lv Y; Su C; Lu W; Zhang R; Li J; Guo B; Yan H; Liu D; Yang Z; Mi H; Mo L; Guo Y; Feng W; Xu H; Peng W; Cheng J; Nan A; Mo Z
Cancer Res; 2023 Mar; 83(5):700-719. PubMed ID: 36607615
[TBL] [Abstract][Full Text] [Related]
17. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
[TBL] [Abstract][Full Text] [Related]
18.
Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma.
Zhang W; Liu W; Yang Y; Xiao C; Xiao Y; Tan X; Pang Q; Wu H; Hua M; Shi X
Front Oncol; 2023; 13():1102623. PubMed ID: 37035174
[TBL] [Abstract][Full Text] [Related]
20. CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
Zhou Q; Qi Y; Wang Z; Zeng H; Zhang H; Liu Z; Huang Q; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Xu L; Dai B; Guo J; Zhu Y; Zhang W; Xu J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32371459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
